Nausea and vomiting after chemotherapy.
Conditions
Interventions
Intervention group: In the intervention group, one 50 mg oral tablet every 5 hours before chemotherapy up to 5 days after chemotherapy.
Sponsors
Shahre-kord University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: The definitive diagnosis of cancer by a physician and pathologist Age 18-70 years One day chemotherapy courses or at least one chemistry course History of vomiting experience following previous chemistry sessions The normality of hematological and biochemical laboratory values Lack of concomitant radiotherapy with chemotherapy (total or upper abdominal) Absence of vomiting diseases such as chronic kidney failure, liver failure, gastrointestinal problems and hypertension Absence of coagulation problems and blood disorders such as severe thrombocytopenia Patient's informed consent
Exclusion criteria
Exclusion criteria: 1. Make allergies to medicines Use of other medicines or treatments other than the usual nausea and vomiting medications prescribed Problems and complications of gastrointestinal obstruction during the study Unwillingness to continue participating in
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number and severity of nausea and vomiting. Timepoint: Daily from 5 days before chemotherapy to 5 days after From chemotherapy. Method of measurement: Questionnaire for recording the number and severity of nausea and vomiting. | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of Life. Timepoint: Daily from 5 days before chemotherapy to 5 days after chemotherapy. Method of measurement: questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFateme Salehi Choliche
Shahre-kord University of Medical Sciences
Outcome results
None listed